 - Evidence of active autoimmune hemolytic anemia, immune thrombocytopenia, or pure red blood cell aplasia Other active primary malignancy requiring treatment or that limits survival to 2 years Any major surgery 4 weeks prior to registration Concurrent investigational drug therapy Any of the following: pregnant women,nursing women, men or women of childbearing potential who are unwilling to employ adequate contraception condoms, diaphragm, birth control pills, injections, intrauterine device IUD, surgical sterilization, abstinence, etc. 